In 2013, Chloe and her little sister both had summer colds. But Chloe’s was accompanied by a sore back, and her fever and pain kept coming and going for a period of several weeks.
After additional blood tests by her pediatrician, Chloe was admitted to the local children’s hospital, where doctors found she had acute lymphoblastic leukemia. Within 48 hours, Chloe was a patient at St. Jude Children's Research Hospital.
St. Jude's groundbreaking development of combination therapy for children with acute lymphoblastic leukemia, the most common form of childhood cancer, revolutionized leukemia therapy worldwide and increased the survival rate from 4 percent when St. Jude opened in 1962 to 94 percent today.
“Our pediatrician said, 'She would get good treatment other places, but on a personal level, if it was my child, it would not even be a question. St. Jude is where we would go,’” said Chloe’s mom, Holly. “Obviously from the minute she was here, we were reassured that that was true. St. Jude is just so much focused around the kids.”
Chloe, a smart 7-year-old, has her own opinions to share about St. Jude. “I think it’s nice, and everyone here takes really good care of me. It’s like St. Jude is the right kind of medicine for me.”
Chloe has several months of chemotherapy left before completing her treatment. She visits St. Jude every three months and receives the rest of her treatment at the St. Jude affiliate closer to her home, which helps keep her life a little more normal.
She enjoys playing outside, playing with her little sister and baby brother, and coloring. Chloe loves learning, and her favorite colors are pink and purple.